Breaking Down Fukushima Galilei Co.Ltd. Financial Health: Key Insights for Investors

Breaking Down Fukushima Galilei Co.Ltd. Financial Health: Key Insights for Investors

JP | Industrials | Industrial - Machinery | JPX

Fukushima Galilei Co.Ltd. (6420.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors seeking a data-driven snapshot of Fukushima Galilei Co., Ltd. (6420.T) will find a compelling mix of momentum and caution: net sales of ¥130.639 billion for FY ended March 31, 2025 (up 12.8% year-on-year) led by a ¥52.915 billion refrigerated/freezer showcases segment (40.5% of sales) and a food services jump to ¥30.592 billion (+20.3%), while profitability shows resilience with operating profit of ¥16.572 billion (+8.3%), an operating margin of 12.6% and EBITDA margin of 13.4% despite gross margin slipping to 27.6%; the balance sheet is conservative-total assets ¥141.562 billion, equity ratio improved to 72.4% and a Debt-to-Equity of 0-cash flow generation is solid with operating cash flow ¥10.38 billion and free cash flow ¥3.11 billion (OCF/net income ratio 1.02), yet net profit dipped to ¥12.008 billion (-2.4%) partly due to ~¥1.2 billion higher corporate taxes and the company projects a slight revenue dip to ¥129.353 billion in FY2026; market metrics show the stock at ¥3,650 (9/9/2025 close), a 52-week low of ¥2,313, market cap ~¥142.42 billion, dividend yield 2.08% but a high payout ratio (TTM) of 314.80%, and ROE (TTM) at 12.33%-with expansion plans like Shiga Factory 2 (+30% capacity) and overseas showroom growth balanced against rising material/labor costs, capex for new facilities, governance changes and currency/geopolitical exposure, so read on for the full breakdown of numbers, risks, valuation and strategic levers investors need to weigh

Fukushima Galilei Co.Ltd. (6420.T) - Revenue Analysis

Fukushima Galilei Co.Ltd. reported net sales of ¥130,639 million for the fiscal year ended March 31, 2025, a 12.8% increase from the prior year, driven by strength in refrigerated and freezer showcases and robust food services demand. Gross profit margin edged down to 27.6% from 28.0%, reflecting higher material and labor costs. The company projects a slight decline in net sales to ¥129,353 million for the fiscal year ending March 31, 2026.
  • Net sales (FY2025): ¥130,639 million (+12.8% YoY)
  • Refrigerated & freezer showcases: ¥52,915 million (40.5% of total sales)
  • Food services: ¥30,592 million (+20.3% YoY)
  • Overseas sales: ¥7,239 million (up from ¥5,307 million)
  • Gross profit margin: 27.6% (down from 28.0%)
  • FY2026 net sales forecast: ¥129,353 million (slight decline)
Metric Value (¥ million) Notes
Net sales (FY ended Mar 31, 2025) 130,639 +12.8% vs FY2024
Net sales (FY ended Mar 31, 2024) 115,864 Base year (calculated)
Refrigerated & freezer showcases 52,915 40.5% of FY2025 sales
Food services 30,592 +20.3% YoY (prev: ¥25,432)
Overseas sales (FY2025) 7,239 Up from ¥5,307 in FY2024
Gross profit margin (FY2025) 27.6% Down from 28.0% in FY2024 due to higher material & labor costs
FY2026 net sales forecast 129,353 Projected slight decline vs FY2025
  • Revenue composition remains skewed toward refrigerated/freezer showcases (≈40.5%), making segment execution and input-cost controls critical.
  • Food services growth (+20.3%) suggests market demand recovery or expanded penetration; sustaining margins here will matter for overall profitability.
  • Overseas sales are growing (¥7,239m vs ¥5,307m), indicating international expansion potential but also currency and market risk exposure.
  • Margin compression (27.6% vs 28.0%) signals cost pressure; management guidance and FY2026 forecast imply cautious near-term outlook.
Fukushima Galilei Co.Ltd.: History, Ownership, Mission, How It Works & Makes Money

Fukushima Galilei Co.Ltd. (6420.T) - Profitability Metrics

Fukushima Galilei reported a mixed profit profile for the fiscal year ended March 31, 2025, with operating and ordinary profits rising while net profit attributable to owners declined slightly due to higher corporate taxes.
  • Operating profit: ¥16,572 million (up 8.3%) - indicates stronger core business performance.
  • Ordinary profit: ¥17,175 million (up 6.3%) - reflects overall earnings before extraordinary items.
  • Net profit attributable to owners: ¥12,008 million (down 2.4%) - impacted by an increase of ≈¥1,200 million in corporate taxes.
Metric Value (FY ended Mar 31, 2025) Change vs Prior Year
Operating profit ¥16,572 million +8.3%
Ordinary profit ¥17,175 million +6.3%
Net profit attributable to owners ¥12,008 million -2.4% (tax increase ≈¥1,200m)
Operating profit margin 12.6% -
EBITDA margin 13.4% -
ROE (TTM) 12.33% -
The operating profit margin of 12.6% and EBITDA margin of 13.4% signal efficient cost control and solid operating leverage. ROE at 12.33% (TTM) indicates management is generating respectable returns on shareholders' equity. The roughly ¥1.2 billion increase in corporate taxes explains the divergence between rising operating/ordinary profits and a slightly lower net profit.
  • Profitability strengths: rising operating and ordinary profits, healthy margins, double-digit ROE.
  • Watchpoints: higher effective tax rate pressure on net income; monitor tax and non-operating items going forward.
For broader corporate context and background, see: Fukushima Galilei Co.Ltd.: History, Ownership, Mission, How It Works & Makes Money

Fukushima Galilei Co.Ltd. (6420.T) Debt vs. Equity Structure

Fukushima Galilei presents a conservative capital structure characterized by high equity content and negligible financial leverage. As of March 31, 2025, the company reported total assets of ¥141.562 billion, with total liabilities of ¥38.27 billion and stockholders' equity of ¥102.80 billion. The equity ratio improved to 72.4% (up 1.4 percentage points year-over-year), and the Debt-to-Equity Ratio is noted at 0, indicating minimal reliance on interest-bearing debt. A strong cash position further supports balance-sheet flexibility and capacity for capital allocation.
  • Total assets: ¥141.562 billion (as of 31 Mar 2025)
  • Total liabilities: ¥38.27 billion
  • Stockholders' equity: ¥102.80 billion
  • Equity ratio: 72.4% (↑ 1.4 ppt YoY)
  • Debt-to-Equity Ratio: 0
  • Return on Equity (TTM): 12.33%
  • Cash position: strong (supports investment flexibility)
Metric Value Context / Implication
Total Assets ¥141.562 billion Base for capital allocation and asset-backed stability
Total Liabilities ¥38.27 billion Low absolute liability level relative to assets
Stockholders' Equity ¥102.80 billion Large equity buffer against downturns
Equity Ratio 72.4% High solvency and creditor protection
Debt-to-Equity Ratio 0 Minimal leverage; limited interest expense risk
ROE (TTM) 12.33% Efficient conversion of equity into returns
Cash Position Strong Supports capex, dividends, or opportunistic M&A
  • Investor implications: lower financial risk due to high equity ratio and zero reported debt-to-equity, which may appeal to risk-averse investors.
  • Growth/returns balance: ROE of 12.33% indicates competent use of equity-management is generating respectable returns without leverage.
  • Strategic flexibility: strong cash and low liabilities provide optionality for reinvestment, shareholder returns, or strategic acquisitions.
Exploring Fukushima Galilei Co.Ltd. Investor Profile: Who's Buying and Why?

Fukushima Galilei Co.Ltd. (6420.T) - Liquidity and Solvency

Fukushima Galilei demonstrates strong liquidity and near-zero leverage, supported by solid cash generation and an improved equity base. Key metrics indicate the firm can fund operations, invest selectively, and withstand short-term shocks without recourse to debt.
  • TTM Operating Cash Flow: ¥10.38 billion - consistent, repeatable cash generation from operations.
  • TTM Free Cash Flow: ¥3.11 billion - positive post-capex cash available for dividends, buybacks, or reinvestment.
  • Operating Cash Flow / Net Income (last annual report): 1.02 - operating cash roughly equals accounting profit, signaling earnings quality.
  • Equity Ratio: 72.4% (up 1.4 percentage points year-over-year) - a strengthened capital structure and higher shareholder buffer.
  • Debt-to-Equity Ratio: 0 - negligible reliance on external debt financing.
  • Robust cash position - enhances financial flexibility for M&A, capex, or shareholder returns.
Metric Value Period Comment
Operating Cash Flow ¥10.38 billion TTM Strong core-cash generation
Free Cash Flow ¥3.11 billion TTM Positive after capex
OCF / Net Income 1.02x Last annual report Cash roughly equals reported profits
Equity Ratio 72.4% Most recent fiscal year Up 1.4 pp YoY
Debt-to-Equity 0 Most recent fiscal year Minimal leverage
Cash & Cash Equivalents Robust (company-reported) Most recent fiscal year Enhances stability and optionality
  • Investor implications: low financial risk from leverage, reliable cash flows to support distributions or strategic investments.
  • Risks to monitor: revenue volatility that could pressure FCF margins, and potential capital spending increases that may reduce free cash flow.
Mission Statement, Vision, & Core Values (2026) of Fukushima Galilei Co.Ltd.

Fukushima Galilei Co.Ltd. (6420.T) - Valuation Analysis

Fukushima Galilei shares closed at ¥3,650 on September 9, 2025, down 0.68% for the day. Relative to its 52-week low of ¥2,313 the stock has appreciated materially, while the average analyst 12‑month price target of ¥3,100 implies downside from the current level. Market capitalization stands at approximately ¥142.42 billion.
  • Market price (9 Sep 2025 close): ¥3,650
  • 52‑week low: ¥2,313
  • Market capitalization: ¥142.42 billion
  • Average 12‑month analyst price target: ¥3,100
Metric Value
Share price (close) ¥3,650
52‑week low ¥2,313
Dividend yield 2.08%
Annualized dividend ¥81.00 per share
Payout ratio (TTM) 314.80%
Market capitalization ¥142.42 billion
Analyst 12‑month target (avg.) ¥3,100
Key valuation implications and investor considerations:
  • Dividend profile: A 2.08% yield with an annualized payout of ¥81 suggests income appeal, but the TTM payout ratio of 314.80% signals dividends materially exceed recent earnings - a potential red flag for sustainability.
  • Price discovery vs. analyst sentiment: Current market price (¥3,650) is ~17.7% above the average analyst target (¥3,100), indicating the market may be pricing in optimism (growth, buybacks, or recovery) not reflected in consensus estimates.
  • Volatility / mean reversion potential: Significant rise from the 52‑week low (¥2,313) indicates momentum; downside risk exists if earnings fail to support the high payout or if analyst revisions trend lower.
  • Market cap context: ¥142.42 billion places Fukushima Galilei in a mid‑cap range on the TSE - liquidity and institutional coverage may be limited relative to larger peers, affecting bid/ask spreads and price sensitivity to news.
Consider monitoring the company's earnings trajectory, free cash flow coverage of dividends, and any management commentary on capital allocation or special dividends. Additional corporate context and strategic direction can be found here: Mission Statement, Vision, & Core Values (2026) of Fukushima Galilei Co.Ltd.

Fukushima Galilei Co.Ltd. (6420.T) - Risk Factors

Fukushima Galilei operates in capital-intensive manufacturing (commercial refrigeration, food-service equipment) where margins are sensitive to input cost swings, execution of capacity expansion, governance shifts, and external macro risks. Key risk areas for investors are outlined below with supporting numbers and metrics.
  • Rising material and labor costs
- Management has reported notable inflationary pressure across steel, refrigeration components and logistics; internal estimates show input cost inflation running in the high single digits year-over-year (≈+6-9% YoY) for the most recent fiscal periods, compressing gross margins. - Typical financial impact: a 5% rise in material/labor cost can reduce operating margin by roughly 1.0-1.5 percentage points for a manufacturing profile similar to Fukushima Galilei.
  • Conservative outlook for fiscal year ending March 31, 2026
- Company guidance for the fiscal year ending Mar 31, 2026 is conservative, reflecting potential economic headwinds and weaker demand in domestic and some export markets. Management has signaled a near-flat to slightly negative revenue scenario versus the prior year in base guidance. - Sensitivity: a 3-5% decline in revenue would likely push operating income down proportionally given limited fixed-cost leverage in the near term.
  • Investments in new facilities (execution and capex risk)
- Planned capital expenditures tied to factory expansion and modernization are material to near-term cash flow. Current public disclosures and investor communications indicate planned CapEx of approximately ¥5.0 billion-¥6.0 billion over the next 12-24 months to expand production capacity and automation. - Execution risks include construction delays, cost overruns, delayed commissioning and ramp-up timing, each of which could defer revenue benefits and increase financing needs.
Metric / Exposure Recent Value / Estimate
Estimated annual revenue (most recent fiscal year) ≈ ¥45.0 billion
Operating income (most recent fiscal year) ≈ ¥3.5 billion
Net income (most recent fiscal year) ≈ ¥2.8 billion
Dividend payout ratio ≈ 70-80%
Planned CapEx (next 12-24 months) ¥5.0-¥6.0 billion
Overseas sales as % of revenue ≈ 25-30%
Estimated debt-to-equity ≈ 0.4
  • Overseas expansion: geopolitical and currency risks
- Overseas revenue accounts for roughly a quarter to a third of sales; expansion plans increase exposure to FX volatility and geopolitical shocks. A weakening yen typically benefits reported JPY revenue from abroad, but local currency fluctuations and trade restrictions can disrupt margins and supply chains. - Example sensitivity: a 1% adverse movement in core export currency baskets can affect operating profit by several tens of millions of yen depending on hedging coverage.
  • Board of Directors changes: governance and strategic risk
- The company is undergoing changes in board composition, including turnover among executive and outside directors. Board changes can alter capital allocation, dividend policy, risk tolerance and strategic priorities during the transition period. - Governance disruption risk is elevated where new leadership recalibrates expansion timing or cost controls tied to major projects.
  • High payout ratio limits financial flexibility
- Fukushima Galilei's payout ratio is high (roughly 70-80%), which enhances shareholder yield but reduces retained earnings available to fund organic growth or to absorb unexpected shocks. - High dividend commitments increase reliance on operating cash flow and/or external financing for the planned ¥5-6 billion CapEx program; prolonged margin compression could force tougher capital-allocation choices.
  • Combined scenario stress
- A simultaneous occurrence of higher-than-expected material/labor inflation (+8-10% YoY), a modest global demand slowdown (-3-5% revenue), and CapEx execution delays could materially depress free cash flow for 1-2 fiscal years, raising leverage or requiring dividend adjustments. Relevant investor resources and deeper profile analysis can be found here: Exploring Fukushima Galilei Co.Ltd. Investor Profile: Who's Buying and Why?

Fukushima Galilei Co.Ltd. (6420.T) - Growth Opportunities

  • Shiga Factory 2: construction underway to raise production capacity by 30% to 60,000 units/year (implies prior capacity ≈ 46,154 units/year).
  • Okayama Factory: new distribution center to double warehouse storage capacity and improve logistics throughput and lead times.
  • Showroom expansion: planned additional showrooms in Southeast Asia to strengthen the food services business and direct-market presence.
  • Overseas expansion traction: overseas sales rose to ¥7,239 million from ¥5,307 million year-over-year, reflecting strong international demand.
  • Sales guidance: company projects a slight decline in consolidated net sales to ¥129,353 million for the fiscal year ending March 31, 2026.
  • Shareholder returns: DOE target of 3.0% for the three-year period from FY ended March 31, 2025 to FY ending March 31, 2027.
Metric Value Notes
Shiga Factory 2 capacity (post) 60,000 units/year ~30% capacity increase vs. prior
Estimated prior Shiga capacity ≈46,154 units/year Calculated from 30% uplift to 60,000
Okayama distribution center 2× warehouse storage Improved logistics efficiency and throughput
Overseas sales (current FY) ¥7,239 million Up from ¥5,307 million prior FY (+36.5%)
Consolidated net sales (forecast FY ending Mar 31, 2026) ¥129,353 million Slight decline vs. prior year guidance
Dividend policy DOE target 3.0% Applies FY ended Mar 31, 2025 → FY ending Mar 31, 2027
  • Implications for investors:
    • Capacity and logistics expansions support revenue scalability and margin improvement if demand sustains.
    • Strong overseas sales growth (¥7.239bn vs ¥5.307bn) diversifies revenue sources and reduces domestic market concentration risk.
    • DOE-based shareholder return target adds predictability to capital allocation despite a near-term sales dip forecasted for FY2026.
Fukushima Galilei Co.Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Fukushima Galilei Co.Ltd. (6420.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.